Cytokinetics, Inc. (CYTK)
62.58
-0.86
(-1.35%)
USD |
NASDAQ |
Jan 16, 16:00
62.54
-0.04
(-0.06%)
After-Hours: 20:00
Cytokinetics EPS Diluted (Quarterly): -2.552 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 1.079 |
| Molina Healthcare, Inc. | 1.505 |
| Jasper Therapeutics, Inc. | -1.126 |
| Fortrea Holdings, Inc. | -0.1743 |
| Lifecore Biomedical, Inc. | -0.2918 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -306.18M |
| Revenue (Quarterly) | 1.936M |
| Total Expenses (Quarterly) | 308.11M |
| Enterprise Value | 7.883B |
| Gross Profit Margin (Quarterly) | -38.38% |
| Profit Margin (Quarterly) | -15.81K% |
| Earnings Yield | -10.08% |
| Normalized Earnings Yield | -8.824 |